The Most Affordable Compounded Tirzepatide Online in 2026
Compounded tirzepatide runs about $199-297/month across legitimate providers, with MEDVi reporting the lowest published self-pay near $199 and Mochi at $278 all-in. All competitor figures are Provider Reported; none is first-party verified yet. None of these competitor tirzepatide prices is first-party verified in our ledger, so treat them as starting points to confirm directly, and weigh pharmacy transparency and dose coverage alongside the monthly price.
- Compounded tirzepatide ranges ~$199-297/mo across legitimate providers.
- MEDVi reports the lowest published self-pay near $199 (Verification Pending).
- Mochi is ~$278 all-in ($199 medication + $79 required membership).
- No competitor tirzepatide price is first-party verified yet — all Provider Reported.
The pricing landscape
Compounded tirzepatide clusters between about $199 and $297 per month across legitimate telehealth providers. The floor sits higher than compounded semaglutide because tirzepatide's active ingredient is harder to source.
MEDVi reports the lowest published self-pay price, near $199 per month for lower doses, though this is Verification Pending in our ledger. Mochi Health charges $199 for medication plus a required $79 membership, making its all-in cost about $278.
Henry Meds runs about $297 month-to-month, with dose surcharges above the starting dose.
Why nothing is 'verified' yet
An important honesty point: none of these competitor tirzepatide prices is first-party verified in our evidence ledger. We label them Provider Reported or Verification Pending because we have not captured them directly from the provider's own checkout with the full field set.
This matters because provider sites frequently render pricing client-side or change it without notice, and a price from a review aggregator is not the same as a captured price. We do not mark a competitor price Verified until we capture it ourselves.
So this ranking is a category comparison of reported prices, not a verified leaderboard. Treat the numbers as starting points to confirm directly.
| Provider | Medication | All-in | Status |
|---|---|---|---|
| MEDVi | $199 (starting) | $199 | Verification Pending |
| Eden Health | $249-296 | $249-296 | Verification Pending |
| Mochi Health | $199 | $278 (+$79) | Provider Reported |
| Henry Meds | $297 (m2m) | $297+ | Provider Reported |
Comparing effective cost
As with semaglutide, the headline tirzepatide price is not the whole cost. A required membership, dose surcharge, or shipping fee changes the real monthly number. Mochi's $199 medication becomes $278 with its required membership.
Model your cost at your target maintenance dose, because tiered programs climb as you titrate. A program with a low entry price but steep dose surcharges can end up the most expensive at maintenance.
The table below puts the main providers on an all-in basis for comparison.
Beyond price
The cheapest reported tirzepatide is not automatically the best choice. Pharmacy transparency, dose coverage, cancellation terms, and clinical oversight all matter. A slightly higher price from a provider that names its state-licensed pharmacy and holds flat pricing can be better value.
Because tirzepatide is compounded and not FDA-approved, provenance matters especially: confirm the dispensing pharmacy and that a real prescription pathway exists.
Sub-$200 maintenance pricing is a flag to scrutinize, not automatically trust.
| Label | Meaning |
|---|---|
| Verified | First-party captured (none yet for competitor tirz) |
| Provider Reported | Provider-stated, not captured by us |
| Verification Pending | Only secondary sources so far |
The bottom line
Compounded tirzepatide runs about $199-297 per month, with MEDVi reporting the lowest self-pay and Mochi at $278 all-in. All competitor figures are Provider Reported, not first-party verified.
Compare effective cost at your maintenance dose, include required fees, and weigh pharmacy transparency alongside price. Confirm current pricing directly, since our competitor figures are reported rather than captured.
Compounded tirzepatide is not FDA-approved and requires a clinician's prescription.
Frequently asked questions
What is the cheapest compounded tirzepatide?
MEDVi reports the lowest published self-pay near $199/month, but this is Verification Pending. Mochi is ~$278 all-in. Confirm directly, since none is first-party verified.
Why is no tirzepatide price marked Verified?
Because we have not captured any competitor tirzepatide price first-party with the full field set. We label them Provider Reported or Verification Pending until we do.
Why is tirzepatide more expensive than semaglutide?
Its active ingredient is harder to source, which raises the price floor across all legitimate providers.
Is sub-$200 tirzepatide a good deal?
Scrutinize it. Sustained maintenance pricing below the market floor can signal sourcing or safety problems rather than a genuine bargain.
Sources
- FDA — drug labels and compounding status (Drugs@FDA, fda.gov/drugs/human-drug-compounding).
- Provider pricing and manufacturer sources, July 2026.
- Forbes Health, U.S. News reviews, July 2026.
- Evidence policy: evidence policy.